Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Boonen

Showing results (31-40 of 257) with videos related to

Pageof 26
Sort By:
The Journal of Endocrinology|September 3, 2010
Skeletal sexual dimorphism: relative contribution of sex steroids, GH-IGF1, and mechanical loadingFilip Callewaert, Mieke Sinnesael, Evelien Gielen, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|September 24, 2013
Osteoporosis in older men: recent advances in pathophysiology and treatmentMichaël Laurent, Evelien Gielen, Frank Claessens, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 18, 2013
Rare MEFV variants are not associated with risk to develop multiple sclerosis and severity of diseaseIne Pauwels, Leentje Cosemans, Steven Boonen, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 2005
Clinical Review: Sex steroids and the periosteum--reconsidering the roles of androgens and estrogens in periosteal expansionDirk Vanderschueren, Katrien Venken, Jill Ophoff, et al.
Journal of Neuroimmunology|March 24, 2009
KIR2DL4 (CD158d) polymorphisms and susceptibility to multiple sclerosisAn Goris, Rita Dobosi, Steven Boonen, et al.
Journal of Osteoporosis|September 24, 2011
Testosterone and the male skeleton: a dual mode of actionMieke Sinnesael, Steven Boonen, Frank Claessens, et al.
Current Osteoporosis Reports|January 10, 2012
Inhibition of cathepsin K for treatment of osteoporosisSteven Boonen, Elizabeth Rosenberg, Frank Claessens, et al.
Annals of Internal Medicine|June 4, 2008
Review of comparative effectiveness of treatments to prevent fracturesDennis M Black, Steven Boonen, Pierre Delmas, et al.
Cellular and Molecular Life Sciences : CMLS|November 22, 2011
Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actionsVanessa Dubois, Michaël Laurent, Steven Boonen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 30, 2005
Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studiesSteven Boonen, Roland F Laan, Ian P Barton, et al.
Pageof 26

Showing results (31-40 of 257) with videos related to

Sort By:
Pageof 26
The Journal of Endocrinology|September 3, 2010
Skeletal sexual dimorphism: relative contribution of sex steroids, GH-IGF1, and mechanical loadingFilip Callewaert, Mieke Sinnesael, Evelien Gielen, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|September 24, 2013
Osteoporosis in older men: recent advances in pathophysiology and treatmentMichaël Laurent, Evelien Gielen, Frank Claessens, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 18, 2013
Rare MEFV variants are not associated with risk to develop multiple sclerosis and severity of diseaseIne Pauwels, Leentje Cosemans, Steven Boonen, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 2005
Clinical Review: Sex steroids and the periosteum--reconsidering the roles of androgens and estrogens in periosteal expansionDirk Vanderschueren, Katrien Venken, Jill Ophoff, et al.
Journal of Neuroimmunology|March 24, 2009
KIR2DL4 (CD158d) polymorphisms and susceptibility to multiple sclerosisAn Goris, Rita Dobosi, Steven Boonen, et al.
Journal of Osteoporosis|September 24, 2011
Testosterone and the male skeleton: a dual mode of actionMieke Sinnesael, Steven Boonen, Frank Claessens, et al.
Current Osteoporosis Reports|January 10, 2012
Inhibition of cathepsin K for treatment of osteoporosisSteven Boonen, Elizabeth Rosenberg, Frank Claessens, et al.
Annals of Internal Medicine|June 4, 2008
Review of comparative effectiveness of treatments to prevent fracturesDennis M Black, Steven Boonen, Pierre Delmas, et al.
Cellular and Molecular Life Sciences : CMLS|November 22, 2011
Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actionsVanessa Dubois, Michaël Laurent, Steven Boonen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 30, 2005
Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studiesSteven Boonen, Roland F Laan, Ian P Barton, et al.
Pageof 26